• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4616375)   Today's Articles (3183)   Subscriber (49396)
For: Pryor JB, Weber BR, Weber JV, Lockridge JB, Olyaei AJ. Lipid-lowering agents for the treatment of hyperlipidemia in patients with chronic kidney disease and end-stage renal disease on dialysis: a review. Drugs Ther Perspect 2019;35:431-41. [DOI: 10.1007/s40267-019-00646-4] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/18/2022]
Number Cited by Other Article(s)
1
Elnagar GM, Elseweidy MM, Elkomy NM, Keshawy MM, Fathy OM, Sobh MS, Mahmoud YK. Policosanol ameliorates renal inflammation and pyroptosis in hypercholesterolemic rabbits via modulation of HMGB1/PI3K/mTOR/NLRP3/Caspase-1 pathway. J Funct Foods 2022. [DOI: 10.1016/j.jff.2022.105250] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/14/2022]  Open
2
Shi X, Qu T, Van Pottelbergh G, van den Akker M, De Moor B. A Resampling Method to Improve the Prognostic Model of End-Stage Kidney Disease: A Better Strategy for Imbalanced Data. Front Med (Lausanne) 2022;9:730748. [PMID: 35321465 PMCID: PMC8935060 DOI: 10.3389/fmed.2022.730748] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/25/2021] [Accepted: 01/17/2022] [Indexed: 12/12/2022]  Open
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA